The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis

Several key new developments regarding drug-resistant tuberculosis are outlined in this Commission Update, including detail on the WHO guidelines on treating drug-resistant tuberculosis which were updated in2019 with a reclassification of second line anti-tuberculosis drugs.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news